Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2005

View Archived Issues

Altastaph reported to shorten hospital stay in adult patients with S. aureus bacteremia

Eszopiclone shows efficacy in insomnia associated with MDD

A specific inhibitor of Akt shows antitumor activity and low toxicity in rodents

Antiinflammatory activity of glabridin in a mouse sepsis model

TRPV1 agonist effective against urinary incontinence in preclinical model

Parenteral glutamine reported to increase hsp70 levels in critically ill patients

Melanocortin-4 receptor antagonist potentially useful for the treatment of cachexia

Similar efficacy found for darbepoetin alfa and epoetin alfa in chemotherapy-induced anemia

Data supports development of iroxanadine for cardiovascular diseases

Arimoclomol shows potential for type 2 diabetes in rat studies

Approvable letter for contrast agent MS-325

CR-001 shows potential as antithrombosis drug

Labopharm's once-daily tramadol approved in France

Alvesco launched in U.K.

Enrollment complete in phase I study of Davanat/5-FU

Two new phase II trials evaluate Discovery's Surfactant Replacement Therapy

Evidence suggests an association between resistin and insulin resistance in humans

New data on the pharmacokinetics and pharmacodynamics of oral insulin spray

Tea flavanoid tested in septic shock model

Novel, broad-spectrum chemokine inhibitor shows good pharmacological profile

AstraZeneca patent discloses delta-opioid agonists for pain

Scientists at CSIC report calpain inhibitors

Novel antimitotic compounds in early development at Cytokinetics

Antiinfective agents claimed by Dr. Reddy's

New compositions for cancer diagnosis and therapy

University of Pennsylvania scientists patent new methods for the treatment of cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...